Urinary Tract Infection Treatment Market Set to Expand, Forecast to Reach $11.74 Billion by 2028

The Business Research Company’s Urinary Tract Infection Treatment Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 4, 2024 /EINPresswire.com/ — The urinary tract infection (UTI) treatment market addresses medical interventions aimed at combating bacterial infections affecting the urinary system, encompassing the bladder, urethra, ureters, kidneys, and associated structures.

Market Size and Growth Drivers
The urinary tract infection treatment market has shown consistent growth, projected to increase from $10.12 billion in 2023 to $10.45 billion in 2024, achieving a compound annual growth rate (CAGR) of 3.3%. This growth is historically attributed to advancements in antibiotics, widespread use of urinary catheters, adherence to clinical guidelines, heightened patient awareness, and focused research in women’s health.

Moving forward, the market is anticipated to continue its expansion, reaching $11.74 billion by 2028, growing at a CAGR of 2.9%. This growth trajectory is driven by the development of non-antibiotic treatment options, the rise in antibiotic-resistant bacterial strains, personalized treatment protocols, the integration of telemedicine and remote consultations, and robust public health awareness initiatives. Key trends in the forecast period include the adoption of microbiome-based therapies, phage therapy, point-of-care testing, nutritional interventions, preventive strategies, and community-based healthcare interventions.

Explore the global urinary tract infection treatment market with detailed insights:

Major Players and Market Trends
Prominent companies in the urinary tract infection treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., and others. These industry leaders are actively involved in innovating new products to address market demands. For example, Taiho Pharmaceutical Co. Ltd. introduced Harncare Bearberry tablets in March 2022, a herbal remedy aimed at alleviating symptoms associated with lower urinary tract infections (UTIs).

Urinary Tract Infection Treatment Market Segments
The urinary tract infection treatment market is segmented based on:
• Drug Class: Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nitrofurantoin
• Indication: Complicated UTI, Uncomplicated UTI
• Distribution Channel: Hospital Pharmacies, Gynecology And Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Store

Geographical Insights
In 2023, North America emerged as the largest region in the urinary tract infection treatment market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth during the forecast period. Detailed regional dynamics and growth opportunities are covered comprehensively in the report.
Explore the report store to make a direct purchase of the report

Urinary Tract Infection Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Urinary Tract Infection Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on urinary tract infection treatment market size, urinary tract infection treatment market drivers and trends, urinary tract infection treatment market major players, competitors’ revenues, market positioning, and market growth across geographies. The urinary tract infection treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Hospital Acquired Infections Testing Kits Global Market Report 2024

Veterinary Infectious Disease Diagnostics Global Market Report 2024

Hospital-Acquired Infection Control Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn